Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07444762) titled 'Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Daewon Pharmaceutical Co., Ltd.
Condition:
Primary Hypercholesterolemia
Mixed Dyslipidemia
Intervention:
Drug: DW5421A
Drug: DW5421B Placebo
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: April 21, 2025
Target Sample Size: 184
Countries of Re...